Advertisement

---

NEUROCRINE BIOSCIENCES, INC.

Neurocrine Announces Completion Of Enrollment Into Kinect Study For Treatment Of Tardive Dyskinesia

[2013-07-01] - Phase IIB Study Evaluating Twelve Weeks of Continuous Dosing With NBI-98854


Neurocrine Biosciences to Present at the Jefferies 2013 Global Healthcare Conference

[2013-05-29] - Live Audio Webcast Wednesday, June 5, 2013


Neurocrine Biosciences to Present at the Jefferies 2013 Global Healthcare Conference

[2013-05-29] - Live Audio Webcast Wednesday, June 5, 2013


Neurocrine Biosciences to Present At The Deutsche Bank 38th Annual dbAccess Health Care Conference

[2013-05-23] - Live Audio Webcast Thursday, May 30, 2013


Neurocrine Biosciences To Present At The Bank of America Merrill Lynch 2013 Health Care Conference

[2013-05-09] - Live Audio Webcast Thursday, May 16, 2013


Advertisement
Most read: scientific news

More:

---


---
Follow us...

google plus Facebook twitter Newsletter

---


---

Plan du site

Actualités

Actualités

Actualités

Réglementaire

Emploi

Annuaires

Dictionnaire

Divers